Delivery Order SPE2DB25D7060-SPE2DB25FXSUA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,432.38 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order, with no set-aside designation, represents a routine procurement of a hormonal contraceptive product to support military healthcare needs. The order is being fulfilled from AmerisourceBergen's place of performance in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, a contraceptive medical device. This competitively awarded, non-set-aside delivery order has a ceiling value of $2,152.08 with a firm fixed price structure and an ultimate completion date of September 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.04 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award carries no set-aside designation, indicating it was competitively awarded. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a $12,219.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 23, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.04 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on September 5, 2025, with completion expected by September 8, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,586.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with a completion date of September 15, 2025. This delivery order, issued on September 12, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, direct order placed against AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings valued at $1,793.40 under a firm fixed price contract type. The award, made on August 12, 2025, represents a single delivery order with an ultimate completion date of August 13, 2025, and involves no set-aside designation, indicating competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,496.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of June 9, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $1,068.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on September 4, 2025, with completion expected by September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The etonogestrel-EE vaginal ring is a hormonal contraceptive product used...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSUADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,152.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed price delivery order was awarded without set-aside consideration and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with the DLA. The contraceptive product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor supplying an extensive range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract award demonstrates the company's established capability to fulfill federal medical procurement requirements through open competition and its role as a primary pharmaceutical supplier for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/15/25 |